AMY HARRISON: Open Payments
NPI 1265035422 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 20 payments from 10 companies in 2025. Trend: 2023 $13 · 2024 $38 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Astellas Pharma US Inc | 2 | $54 |
| PFIZER INC. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
| Novo Nordisk Inc | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: FANAPT, REXULTI, Veozah, CAPLYTA, The Cologuard Plus Collection Kit, NURTEC ODT, Ozempic, PREVNAR 20.
Industry payments across IN — which companies pay providers there.
